Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Jun-23 4:14 PM View:  | Revolution Medicines, Inc. (RVMD) | 08-Jun-23 | Grant | 5,200 | -- | -- | 32% 16.05K to 21.25K | |
| 24-Mar-23 8:17 PM View: | Allogene Therapeutics, Inc. (ALLO) | 22-Mar-23 | Grant | 558,094 | -- | -- | 38% 1.46M to 2.02M | |
| 16-Mar-23 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 14-Mar-23 | Payment of Exercise | 35,879 | $5.47 | $196,258.00 | (2%) 1.49M to 1.46M | |
| 17-Jun-22 5:04 PM View: | Revolution Medicines, Inc. (RVMD) | 16-Jun-22 | Grant | 5,200 | -- | -- | 48% 10.85K to 16.05K | |
| 25-Mar-22 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 23-Mar-22 | Grant | 237,358 | -- | -- | 19% 1.25M to 1.49M | |
| 17-Mar-22 5:58 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-22 | Sale | 11,469 | $7.63 | $87,550.90 | (< 1%) 1.26M to 1.25M | |
| 24-Jun-21 5:17 PM View: | Revolution Medicines, Inc. (RVMD) | 22-Jun-21 | Grant | 3,617 | -- | -- | 50% 7.23K to 10.85K | |
| 26-May-21 8:00 AM View: | Allogene Therapeutics, Inc. (ALLO) | 24-May-21 | Option Exercise | 14,897 | $18.22 | $271,423.00 | 1% 1.25M to 1.26M | |
| 30-Mar-21 4:51 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Mar-21 | Grant | 24,866 | -- | -- | 2% 1.22M to 1.25M | |
| 17-Mar-21 5:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Market Sale | 8,053 | $38.23 | $307,889.00 | (< 1%) 1.23M to 1.22M | < 1% |
| 19-Jan-21 4:31 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Jan-21 | Market Sale (Planned) | 15,000 | $32.26 | $483,859.00 | (1%) 1.25M to 1.23M | (< 1%) |
| 19-Jan-21 4:31 PM View: | Allogene Therapeutics, Inc. (ALLO) | 14-Jan-21 | Market Sale (Planned) | 15,000 | $30.77 | $461,610.00 | (1%) 1.26M to 1.25M | (5%) |
| 18-Nov-20 4:36 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Nov-20 | Market Sale (Planned) | 15,000 | $32.88 | $493,146.00 | (1%) 1.28M to 1.26M | 16% |
| 16-Oct-20 6:55 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-20 | Market Sale (Planned) | 15,000 | $40.49 | $607,392.00 | (1%) 1.29M to 1.28M | 32% |
| 22-Sep-20 4:48 PM View: | Allogene Therapeutics, Inc. (ALLO) | 21-Sep-20 | Market Sale (Planned) | 15,000 | $35.30 | $529,545.00 | (1%) 1.31M to 1.29M | 22% |
| 19-Jun-20 3:33 PM View: | Revolution Medicines, Inc. (RVMD) | 17-Jun-20 | Grant | 7,234 | -- | -- | 100% 0 to 7.23K | |
| 09-Apr-20 4:37 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Apr-20 | Exercise (in-the money or at-the-money) | 45,000 | $6.83 | $307,500.00 | 82% 55.0K to 100.0K | |
| 20-Mar-20 4:36 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Mar-20 | Grant | 30,800 | -- | -- | 2% 1.28M to 1.31M | |
| 18-Mar-20 4:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Mar-20 | Market Sale | 5,450 | $19.73 | $107,508.00 | (< 1%) 1.28M to 1.28M | (40%) |
| 24-Feb-20 5:14 PM View: | Allogene Therapeutics, Inc. (ALLO) | 20-Feb-20 | Disposition (other) | 237,155 | $25.30 | $6,000,020.00 | (16%) 1.52M to 1.28M | (9%) |
| 15-Mar-19 5:21 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Mar-19 | Grant | 49,400 | -- | -- | 3% 1.46M to 1.51M |